Pegylated liposomal doxorubicin (Duomeisu®) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study

被引：0
|
作者：
Hanfang Jiang
Huiping Li
Guohong Song
Lijun Di
Bin Shao
Ying Yan
Xiaoran Liu
Yifei Chen
Ruyan Zhang
Ran Ran
Yaxin Liu
Xinyu Gui
Nan Wang
Huan Wang
机构：
[1] Peking University Cancer Hospital & Institute,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology
来源：
Breast Cancer Research and Treatment | 2023年 / 199卷
关键词：
Pegylated liposomal doxorubicin; Metastatic breast cancer; HER2-negative; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：67 / 79
页数：12
相关论文
共 50 条
  • [21] Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients
    Pin Zhang
    Zhongsheng Tong
    Fuguo Tian
    Yongsheng Wang
    Junlan Yang
    Weilian Li
    Lijun Di
    Wei Liu
    Li Tang
    Rongguo Qiu
    Binghe Xu
    Journal of Hematology & Oncology, 9
  • [22] Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer
    Yoshimoto, Masataka
    Takao, Shintaro
    Hirata, Masaru
    Okamoto, Yasushi
    Yamashita, Sumio
    Kawaguchi, Yoshihiro
    Takami, Makoto
    Furusawa, Hidemi
    Morita, Satoshi
    Abe, Chigusa
    Sakamoto, Junichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (02) : 331 - 338
  • [23] A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer
    Ford, Hugo E. R.
    Yap, Yoon-Sim
    Miles, David W.
    Makris, Andreas
    Hall, Marcia
    Miller, Liz
    Harries, Mark
    Smith, Ian E.
    Johnston, Stephen R. D.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (06) : 809 - 815
  • [24] A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer
    Hugo E. R. Ford
    Yoon-Sim Yap
    David W. Miles
    Andreas Makris
    Marcia Hall
    Liz Miller
    Mark Harries
    Ian E. Smith
    Stephen R. D. Johnston
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 809 - 815
  • [25] Addition of Bevacizumab to Vinorelbine-Platinum combination is efficacious in Heavily Pretreated HER2-Negative Metastatic Breast Cancer
    Ho, I. -Wei
    Tseng, Yi-Ru
    Liu, Chun-Yu
    Tsai, Yi-Fang
    Huang, Chi-Cheng
    Tseng, Ling-Ming
    Chao, Ta-Chung
    Lai, Jiun-, I
    JOURNAL OF CANCER, 2025, 16 (05): : 1726 - 1735
  • [26] A phase II study of eribulin in Japanese patients with heavily pretreated metastatic breast cancer
    Aogi, K.
    Iwata, H.
    Masuda, N.
    Mukai, H.
    Yoshida, M.
    Rai, Y.
    Taguchi, K.
    Sasaki, Y.
    Takashima, S.
    ANNALS OF ONCOLOGY, 2012, 23 (06) : 1441 - 1448
  • [27] Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center
    Salah Mabrouk Khallaf
    Jasmine Roshdy
    Abeer Ibrahim
    Journal of the Egyptian National Cancer Institute, 32
  • [28] Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center
    Khallaf, Salah Mabrouk
    Roshdy, Jasmine
    Ibrahim, Abeer
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2020, 32 (01)
  • [29] Phase II study of pegylated liposomal doxorubicin (Caelyx®) and docetaxel as first-line treatment in metastatic breast cancer
    Alexopoulos, A
    Karamouzis, MV
    Stavrinides, H
    Ardavanis, A
    Kandilis, K
    Stavrakakis, J
    Georganta, C
    Rigatos, G
    ANNALS OF ONCOLOGY, 2004, 15 (06) : 891 - 895
  • [30] A phase II study of capecitabine plus cisplatin in metastatic triple-negative breast cancer patients pretreated with anthracyclines and taxanes
    Li, Qiao
    Li, Qing
    Zhang, Pin
    Yuan, Peng
    Wang, Jiayu
    Ma, Fei
    Luo, Yang
    Fan, Ying
    Cai, Ruigang
    Xu, Binghe
    CANCER BIOLOGY & THERAPY, 2015, 16 (12) : 1746 - 1753
12345